EXPLORE!

FDA approves latest generation Sapien 3 device for TAVR

  980 Views

eMediNexus    31 December 2018

The FDA approved the latest generation Sapien 3 device, Ultra, for transcatheter aortic valve replacement (TAVR) for treatment of severe, symptomatic aortic stenosis in patients at intermediate or greater risk of open-heart surgery.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.